ASSENT I-(TIMI 10C) compared the safety of several doses of TNK-tPA with rtPA in 3,235 patients with ST elevation myocardial infarction. MAIN RESULTS: Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. Am Heart J. 1999 May;137(5):786-91. PRESENTATIONS TIMI 10C Slides OTHER PUBLICATIONS Determination of a weight-adjusted dose … Continue reading ASSENT 1-TIMI 10C